Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation.

Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation.

<h4>Background</h4>The optimal timing of initiating oral anticoagulants after reperfusion therapy for ischemic stroke is unknown. Factors related to early initiation of rivaroxaban and differences in clinical outcomes of stroke patients with nonvalvular atrial fibrillation (NVAF) who und...

Celý popis

Podrobná bibliografie
Hlavní autoři: Junpei Koge, Hiroshi Yamagami, Kazunori Toyoda, Masahiro Yasaka, Teruyuki Hirano, Toshimitsu Hamasaki, Takehiko Nagao, Shinichi Yoshimura, Masahito Fujishige, Akira Tempaku, Shinichiro Uchiyama, Etsuro Mori, Masatoshi Koga, Kazuo Minematsu
Médium: Článek
Jazyk:English
Vydáno: Public Library of Science (PLoS) 2022-01-01
Edice:PLoS ONE
On-line přístup:https://doi.org/10.1371/journal.pone.0264760

Internet

https://doi.org/10.1371/journal.pone.0264760

Podobné jednotky